カテゴリー： QYResearch, 世界

世界のレーバー遺伝性視神経萎縮症薬市場

◆英語タイトル：Global Leber's Hereditary Optic Neuropathy Drug Market Professional Survey Report 2019
◆商品コード：DATA909X10429
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：105
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、レーバー遺伝性視神経萎縮症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エラミプレチド、GS-011、IXC-201、KH-176、その他に、用途別には、病院、診療所、その他にセグメント区分し、レーバー遺伝性視神経萎縮症薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・レーバー遺伝性視神経萎縮症薬の世界市場概要
・レーバー遺伝性視神経萎縮症薬の製造コスト構成分析
・レーバー遺伝性視神経萎縮症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・レーバー遺伝性視神経萎縮症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・レーバー遺伝性視神経萎縮症薬のセグメント分析（種類別）
（エラミプレチド、GS-011、IXC-201、KH-176、その他）
・レーバー遺伝性視神経萎縮症薬のセグメント分析（用途別）
（病院、診療所、その他）
・レーバー遺伝性視神経萎縮症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Alkeus Pharmaceuticals, Inc.、Biovista Inc.、GenSight Biologics S.A.、Ixchel Pharma, LLC、Khondrion BV、Spark Therapeutics, Inc.、Stealth BioTherapeutics Inc.、）
・レーバー遺伝性視神経萎縮症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Leber’s Hereditary Optic Neuropathy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Leber’s Hereditary Optic Neuropathy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leber’s Hereditary Optic Neuropathy Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Leber’s Hereditary Optic Neuropathy Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Leber’s Hereditary Optic Neuropathy Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Alkeus Pharmaceuticals, Inc.
Biovista Inc.
GenSight Biologics S.A.
Ixchel Pharma, LLC
Khondrion BV
Spark Therapeutics, Inc.
Stealth BioTherapeutics Inc.
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Elamipretide
GS-011
IXC-201
KH-176
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Leber’s Hereditary Optic Neuropathy Drug
1.1 Definition of Leber’s Hereditary Optic Neuropathy Drug
1.2 Leber’s Hereditary Optic Neuropathy Drug Segment by Type
1.2.1 Global Leber’s Hereditary Optic Neuropathy Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Elamipretide
1.2.3 GS-011
1.2.4 IXC-201
1.2.5 KH-176
1.2.6 Others
1.3 Leber’s Hereditary Optic Neuropathy Drug Segment by Applications
1.3.1 Global Leber’s Hereditary Optic Neuropathy Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Leber’s Hereditary Optic Neuropathy Drug Overall Market
1.4.1 Global Leber’s Hereditary Optic Neuropathy Drug Revenue (2014-2025)
1.4.2 Global Leber’s Hereditary Optic Neuropathy Drug Production (2014-2025)
1.4.3 North America Leber’s Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
1.4.4 Europe Leber’s Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
1.4.5 China Leber’s Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
1.4.6 Japan Leber’s Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Leber’s Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)
1.4.8 India Leber’s Hereditary Optic Neuropathy Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Leber’s Hereditary Optic Neuropathy Drug
2.3 Manufacturing Process Analysis of Leber’s Hereditary Optic Neuropathy Drug
2.4 Industry Chain Structure of Leber’s Hereditary Optic Neuropathy Drug

3 Development and Manufacturing Plants Analysis of Leber’s Hereditary Optic Neuropathy Drug
3.1 Capacity and Commercial Production Date
3.2 Global Leber’s Hereditary Optic Neuropathy Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Leber’s Hereditary Optic Neuropathy Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Leber’s Hereditary Optic Neuropathy Drug Production and Capacity Analysis
4.2 Leber’s Hereditary Optic Neuropathy Drug Revenue Analysis
4.3 Leber’s Hereditary Optic Neuropathy Drug Price Analysis
4.4 Market Concentration Degree

5 Leber’s Hereditary Optic Neuropathy Drug Regional Market Analysis
5.1 Leber’s Hereditary Optic Neuropathy Drug Production by Regions
5.1.1 Global Leber’s Hereditary Optic Neuropathy Drug Production by Regions
5.1.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Regions
5.2 Leber’s Hereditary Optic Neuropathy Drug Consumption by Regions
5.3 North America Leber’s Hereditary Optic Neuropathy Drug Market Analysis
5.3.1 North America Leber’s Hereditary Optic Neuropathy Drug Production
5.3.2 North America Leber’s Hereditary Optic Neuropathy Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Leber’s Hereditary Optic Neuropathy Drug Import and Export
5.4 Europe Leber’s Hereditary Optic Neuropathy Drug Market Analysis
5.4.1 Europe Leber’s Hereditary Optic Neuropathy Drug Production
5.4.2 Europe Leber’s Hereditary Optic Neuropathy Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Leber’s Hereditary Optic Neuropathy Drug Import and Export
5.5 China Leber’s Hereditary Optic Neuropathy Drug Market Analysis
5.5.1 China Leber’s Hereditary Optic Neuropathy Drug Production
5.5.2 China Leber’s Hereditary Optic Neuropathy Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Leber’s Hereditary Optic Neuropathy Drug Import and Export
5.6 Japan Leber’s Hereditary Optic Neuropathy Drug Market Analysis
5.6.1 Japan Leber’s Hereditary Optic Neuropathy Drug Production
5.6.2 Japan Leber’s Hereditary Optic Neuropathy Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Leber’s Hereditary Optic Neuropathy Drug Import and Export
5.7 Southeast Asia Leber’s Hereditary Optic Neuropathy Drug Market Analysis
5.7.1 Southeast Asia Leber’s Hereditary Optic Neuropathy Drug Production
5.7.2 Southeast Asia Leber’s Hereditary Optic Neuropathy Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Leber’s Hereditary Optic Neuropathy Drug Import and Export
5.8 India Leber’s Hereditary Optic Neuropathy Drug Market Analysis
5.8.1 India Leber’s Hereditary Optic Neuropathy Drug Production
5.8.2 India Leber’s Hereditary Optic Neuropathy Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Leber’s Hereditary Optic Neuropathy Drug Import and Export

6 Leber’s Hereditary Optic Neuropathy Drug Segment Market Analysis (by Type)
6.1 Global Leber’s Hereditary Optic Neuropathy Drug Production by Type
6.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Type
6.3 Leber’s Hereditary Optic Neuropathy Drug Price by Type

7 Leber’s Hereditary Optic Neuropathy Drug Segment Market Analysis (by Application)
7.1 Global Leber’s Hereditary Optic Neuropathy Drug Consumption by Application
7.2 Global Leber’s Hereditary Optic Neuropathy Drug Consumption Market Share by Application (2014-2019)

8 Leber’s Hereditary Optic Neuropathy Drug Major Manufacturers Analysis
8.1 Alkeus Pharmaceuticals, Inc.
8.1.1 Alkeus Pharmaceuticals, Inc. Leber’s Hereditary Optic Neuropathy Drug Production Sites and Area Served
8.1.2 Alkeus Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.1.3 Alkeus Pharmaceuticals, Inc. Leber’s Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Biovista Inc.
8.2.1 Biovista Inc. Leber’s Hereditary Optic Neuropathy Drug Production Sites and Area Served
8.2.2 Biovista Inc. Product Introduction, Application and Specification
8.2.3 Biovista Inc. Leber’s Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 GenSight Biologics S.A.
8.3.1 GenSight Biologics S.A. Leber’s Hereditary Optic Neuropathy Drug Production Sites and Area Served
8.3.2 GenSight Biologics S.A. Product Introduction, Application and Specification
8.3.3 GenSight Biologics S.A. Leber’s Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Ixchel Pharma, LLC
8.4.1 Ixchel Pharma, LLC Leber’s Hereditary Optic Neuropathy Drug Production Sites and Area Served
8.4.2 Ixchel Pharma, LLC Product Introduction, Application and Specification
8.4.3 Ixchel Pharma, LLC Leber’s Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Khondrion BV
8.5.1 Khondrion BV Leber’s Hereditary Optic Neuropathy Drug Production Sites and Area Served
8.5.2 Khondrion BV Product Introduction, Application and Specification
8.5.3 Khondrion BV Leber’s Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Spark Therapeutics, Inc.
8.6.1 Spark Therapeutics, Inc. Leber’s Hereditary Optic Neuropathy Drug Production Sites and Area Served
8.6.2 Spark Therapeutics, Inc. Product Introduction, Application and Specification
8.6.3 Spark Therapeutics, Inc. Leber’s Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Stealth BioTherapeutics Inc.
8.7.1 Stealth BioTherapeutics Inc. Leber’s Hereditary Optic Neuropathy Drug Production Sites and Area Served
8.7.2 Stealth BioTherapeutics Inc. Product Introduction, Application and Specification
8.7.3 Stealth BioTherapeutics Inc. Leber’s Hereditary Optic Neuropathy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Leber’s Hereditary Optic Neuropathy Drug Market
9.1 Global Leber’s Hereditary Optic Neuropathy Drug Market Trend Analysis
9.1.1 Global Leber’s Hereditary Optic Neuropathy Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Leber’s Hereditary Optic Neuropathy Drug Regional Market Trend
9.2.1 North America Leber’s Hereditary Optic Neuropathy Drug Forecast 2019-2025
9.2.2 Europe Leber’s Hereditary Optic Neuropathy Drug Forecast 2019-2025
9.2.3 China Leber’s Hereditary Optic Neuropathy Drug Forecast 2019-2025
9.2.4 Japan Leber’s Hereditary Optic Neuropathy Drug Forecast 2019-2025
9.2.5 Southeast Asia Leber’s Hereditary Optic Neuropathy Drug Forecast 2019-2025
9.2.6 India Leber’s Hereditary Optic Neuropathy Drug Forecast 2019-2025
9.3 Leber’s Hereditary Optic Neuropathy Drug Market Trend (Product Type)
9.4 Leber’s Hereditary Optic Neuropathy Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Leber’s Hereditary Optic Neuropathy Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Leber's Hereditary Optic Neuropathy Drug
Table Global Leber's Hereditary Optic Neuropathy Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Leber's Hereditary Optic Neuropathy Drug Production Market Share by Types in 2018
Figure Elamipretide Product Picture
Figure GS-011 Product Picture
Figure IXC-201 Product Picture
Figure KH-176 Product Picture
Figure Others Product Picture
Table Global Leber's Hereditary Optic Neuropathy Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Leber's Hereditary Optic Neuropathy Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Leber's Hereditary Optic Neuropathy Drug Revenue (Million USD) (2014-2025)
Figure Global Leber's Hereditary Optic Neuropathy Drug Production (K Pcs) (2014-2025)
Figure North America Leber's Hereditary Optic Neuropathy Drug Market Size (Million USD) (2014-2025)
Figure Europe Leber's Hereditary Optic Neuropathy Drug Market Size (Million USD) (2014-2025)
Figure China Leber's Hereditary Optic Neuropathy Drug Market Size (Million USD) (2014-2025)
Figure Japan Leber's Hereditary Optic Neuropathy Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Leber's Hereditary Optic Neuropathy Drug Market Size (Million USD) (2014-2025)
Figure India Leber's Hereditary Optic Neuropathy Drug Market Size (Million USD) (2014-2025)
Table Leber's Hereditary Optic Neuropathy Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Leber's Hereditary Optic Neuropathy Drug in 2018
Figure Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy Drug
Figure Industry Chain Structure of Leber's Hereditary Optic Neuropathy Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Leber's Hereditary Optic Neuropathy Drug Manufacturing Plants Distribution
Table Leber's Hereditary Optic Neuropathy Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Leber's Hereditary Optic Neuropathy Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Leber's Hereditary Optic Neuropathy Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Leber's Hereditary Optic Neuropathy Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Leber's Hereditary Optic Neuropathy Drug Production Share by Manufacturers in 2018
Table Leber's Hereditary Optic Neuropathy Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Leber's Hereditary Optic Neuropathy Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Leber's Hereditary Optic Neuropathy Drug Revenue Share by Manufacturers in 2018
Table Leber's Hereditary Optic Neuropathy Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Leber's Hereditary Optic Neuropathy Drug Production by Regions 2014-2019 (K Pcs)
Table Global Leber's Hereditary Optic Neuropathy Drug Production Market Share by Regions 2014-2019
Figure Global Leber's Hereditary Optic Neuropathy Drug Production Market Share by Regions in 2018
Table Global Leber's Hereditary Optic Neuropathy Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Regions 2014-2019
Figure Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Regions in 2018
Table Global Leber's Hereditary Optic Neuropathy Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Leber's Hereditary Optic Neuropathy Drug Consumption Market Share by Regions 2014-2019
Figure North America Leber's Hereditary Optic Neuropathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Leber's Hereditary Optic Neuropathy Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Leber's Hereditary Optic Neuropathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Leber's Hereditary Optic Neuropathy Drug Production, Consumption Import and Export (K Pcs)
Figure China Leber's Hereditary Optic Neuropathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Leber's Hereditary Optic Neuropathy Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Leber's Hereditary Optic Neuropathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Leber's Hereditary Optic Neuropathy Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Leber's Hereditary Optic Neuropathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Leber's Hereditary Optic Neuropathy Drug Production, Consumption Import and Export (K Pcs)
Figure India Leber's Hereditary Optic Neuropathy Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Leber's Hereditary Optic Neuropathy Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Leber's Hereditary Optic Neuropathy Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Leber's Hereditary Optic Neuropathy Drug Market Share by Application (2014-2019)
Table Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
Table Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Introduction, Application and Specification
Table Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Production Growth Rate (2014-2019)
Table Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Production Market Share (2014-2019)
Figure Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Revenue Market Share (2014-2019)
Table Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Main Business and Markets Served
Table Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
Table Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Introduction, Application and Specification
Table Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Production Growth Rate (2014-2019)
Table Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Production Market Share (2014-2019)
Figure Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Revenue Market Share (2014-2019)
Table Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Main Business and Markets Served
Table GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
Table GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Introduction, Application and Specification
Table GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Production Growth Rate (2014-2019)
Table GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Production Market Share (2014-2019)
Figure GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Revenue Market Share (2014-2019)
Table GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Main Business and Markets Served
Table Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
Table Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Introduction, Application and Specification
Table Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Production Growth Rate (2014-2019)
Table Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Production Market Share (2014-2019)
Figure Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Revenue Market Share (2014-2019)
Table Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Main Business and Markets Served
Table Khondrion BV Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
Table Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Introduction, Application and Specification
Table Khondrion BV Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Khondrion BV Leber's Hereditary Optic Neuropathy Drug Production Growth Rate (2014-2019)
Table Khondrion BV Leber's Hereditary Optic Neuropathy Drug Production Market Share (2014-2019)
Figure Khondrion BV Leber's Hereditary Optic Neuropathy Drug Revenue Market Share (2014-2019)
Table Khondrion BV Leber's Hereditary Optic Neuropathy Drug Main Business and Markets Served
Table Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
Table Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Introduction, Application and Specification
Table Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Production Growth Rate (2014-2019)
Table Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Production Market Share (2014-2019)
Figure Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Revenue Market Share (2014-2019)
Table Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Main Business and Markets Served
Table Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Production Sites and Area Served
Table Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Introduction, Application and Specification
Table Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Production Growth Rate (2014-2019)
Table Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Production Market Share (2014-2019)
Figure Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Revenue Market Share (2014-2019)
Table Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Main Business and Markets Served
Figure Global Leber's Hereditary Optic Neuropathy Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Leber's Hereditary Optic Neuropathy Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Leber's Hereditary Optic Neuropathy Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Leber's Hereditary Optic Neuropathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Leber's Hereditary Optic Neuropathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Leber's Hereditary Optic Neuropathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Leber's Hereditary Optic Neuropathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Leber's Hereditary Optic Neuropathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Leber's Hereditary Optic Neuropathy Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Leber's Hereditary Optic Neuropathy Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Leber's Hereditary Optic Neuropathy Drug by Application (2019-2025)
Table Leber's Hereditary Optic Neuropathy Drug Distributors List
Table Leber's Hereditary Optic Neuropathy Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Alkeus Pharmaceuticals, Inc.、Biovista Inc.、GenSight Biologics S.A.、Ixchel Pharma, LLC、Khondrion BV、Spark Therapeutics, Inc.、Stealth BioTherapeutics Inc.、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のレーバー遺伝性視神経萎縮症薬市場(Global Leber's Hereditary Optic Neuropathy Drug Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp